NEW YORK (GenomeWeb News) — The Queensland Institute of Medical Research has installed one of Bruker Daltonics’ mass spectrometers for use in its proteomics research, Bruker said today.
QIMR, located in Brisbane, Australia, will use the company’s maXis instruments in its Protein Discovery Center. The maXis system is used in quantitative proteomics, peptide and intact protein analysis, and small molecule identification.
Bruker said that this agreement marks the first installation of this high-resolution, time-of-flight model in the Australasia region.
Bruker Daltonics Executive VP Clive Seymour called the installation “a major opportunity for us to co-develop a wide range of applications undertaken” at the PDC.
“In particular, it will provide the PDC with the scope to collaborate more effectively with scientists from QIMR, Australia and internationally on projects aimed at combating infectious diseases and cancer,” explained PDC Director Jeff Gorman in a statement.
Financial terms of the agreement were not released.